Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Broadening the use of antiretroviral therapy: the case for feline leukemia virus.

Greggs WM 3rd, Clouser CL, Patterson SE, Mansky LM.

Ther Clin Risk Manag. 2011;7:115-22. doi: 10.2147/TCRM.S17731. Epub 2011 Mar 16.

3.

Inhibition of Feline leukemia virus replication by the integrase inhibitor Raltegravir.

Cattori V, Weibel B, Lutz H.

Vet Microbiol. 2011 Aug 26;152(1-2):165-8. doi: 10.1016/j.vetmic.2011.03.039. Epub 2011 Apr 12.

PMID:
21570781
4.

Refrex-1, a soluble restriction factor against feline endogenous and exogenous retroviruses.

Ito J, Watanabe S, Hiratsuka T, Kuse K, Odahara Y, Ochi H, Kawamura M, Nishigaki K.

J Virol. 2013 Nov;87(22):12029-40. doi: 10.1128/JVI.01267-13. Epub 2013 Aug 21.

5.

Efficacy of antiviral chemotherapy for retrovirus-infected cats: What does the current literature tell us?

Hartmann K.

J Feline Med Surg. 2015 Nov;17(11):925-39. doi: 10.1177/1098612X15610676. Review.

PMID:
26486979
6.

Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.

[No authors listed]

Prescrire Int. 2004 Aug;13(72):144-50.

PMID:
15532140
7.

New antiretroviral drugs.

Gulick RM.

Clin Microbiol Infect. 2003 Mar;9(3):186-93. Review.

8.

Feline leukemia virus-induced immunodeficiency syndrome in cats as a model for evaluation of antiretroviral therapy.

Hoover EA, Zeidner NS, Perigo NA, Quackenbush SL, Strobel JD, Hill DL, Mullins JI.

Intervirology. 1989;30 Suppl 1:12-25.

PMID:
2540109
9.

Care of Patients With HIV Infection: Antiretroviral Drug Regimens.

Bolduc P, Roder N, Colgate E, Cheeseman SH.

FP Essent. 2016 Apr;443:23-30. Review.

PMID:
27092564
10.

Current and future antiretroviral treatment options in paediatric HIV infection.

Giaquinto C, Morelli E, Fregonese F, Rampon O, Penazzato M, de Rossi A, D'Elia R.

Clin Drug Investig. 2008;28(6):375-97. Review.

PMID:
18479179
11.

2008 American Association of Feline Practitioners' feline retrovirus management guidelines.

Levy J, Crawford C, Hartmann K, Hofmann-Lehmann R, Little S, Sundahl E, Thayer V.

J Feline Med Surg. 2008 Jul;10(3):300-16. doi: 10.1016/j.jfms.2008.03.002. Epub 2008 May 2.

PMID:
18455463
12.

Investigational antiretroviral drugs.

Sen S, Mathur AG, Gupta RM, Kapila K, Chopra GS.

Recent Pat Antiinfect Drug Discov. 2008 Nov;3(3):199-205. Review.

PMID:
18991802
13.

Emerging drug targets for antiretroviral therapy.

Reeves JD, Piefer AJ.

Drugs. 2005;65(13):1747-66. Review.

PMID:
16114975
14.

Novel targets for antiretroviral therapy: clinical progress to date.

Dau B, Holodniy M.

Drugs. 2009;69(1):31-50. doi: 10.2165/00003495-200969010-00003. Review.

PMID:
19192935
15.

Feline leukemia virus infection as a potentiating cofactor for the primary and secondary stages of experimentally induced feline immunodeficiency virus infection.

Pedersen NC, Torten M, Rideout B, Sparger E, Tonachini T, Luciw PA, Ackley C, Levy N, Yamamoto J.

J Virol. 1990 Feb;64(2):598-606.

16.

Feline leukemia virus and other pathogens as important threats to the survival of the critically endangered Iberian lynx (Lynx pardinus).

Meli ML, Cattori V, Martínez F, López G, Vargas A, Simón MA, Zorrilla I, Muñoz A, Palomares F, López-Bao JV, Pastor J, Tandon R, Willi B, Hofmann-Lehmann R, Lutz H.

PLoS One. 2009;4(3):e4744. doi: 10.1371/journal.pone.0004744. Epub 2009 Mar 9.

17.

Evaluation of in vivo and in vitro interactions of feline immunodeficiency virus and feline leukemia virus.

Beebe AM, Faith TG, Sparger EE, Torten M, Pedersen NC, Dandekar S.

AIDS. 1994 Jul;8(7):873-8.

PMID:
7946095
18.

Lopinavir/ritonavir: a review of its use in the management of HIV infection.

Cvetkovic RS, Goa KL.

Drugs. 2003;63(8):769-802. Review.

PMID:
12662125
19.
20.

In vitro and in vivo evidence that the antiviral activity of 2',3'-dideoxycytidine is target cell dependent in a feline retrovirus animal model.

Polas PJ, Swenson CL, Sams R, Cheney CM, Hayes KA, Tarr MJ, Kociba GJ, Mathes LE.

Antimicrob Agents Chemother. 1990 Jul;34(7):1414-21.

Supplemental Content

Support Center